Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 2 Blood.

Similar presentations


Presentation on theme: "Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 2 Blood."— Presentation transcript:

1 Chapter 19 Agents Affecting Blood Clotting

2 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 2 Blood Clotting Thromboemboli  Cause many deaths per year Anticoagulants  Prevent the formation of coagulants

3 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 3 Anticoagulant Agents Inhibit the formation of clots  Heparin  Found in mast cells  Action  Inhibit the clotting process

4 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 4 Heparin Heparin action  Indirectly interferes with the conversion of prothrombin to thrombin  The deficiency of thrombin prevents the conversion of fibrinogen to fibrin (continues)

5 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 5 Heparin Destroyed if given orally Administered via IV infusion  No intramuscular injections Administered subcutaneously  Longer acting form  No intramuscular injections (continued)

6 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 6 Heparin: Side Effects Hemorrhage Allergy Antidote  Protamine sulfate Caution  Do not administer to clients with coagulation disorders

7 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 7 Low Molecular Weight Anticoagulant Related to heparin  Minor risk for bleeding Does not affect the action of thrombin in the clotting cascade (continues)

8 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 8 Low Molecular Weight Anticoagulant Example: enoxaparim (Lovenox) (continued)

9 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 9 Oral Anticoagulants Warfarin (Coumadin)  Inhibits blood clotting by interfering with the synthesis of vitamin K-dependent clotting factors Close client monitoring  Dosage is individualized  International normalized ratio

10 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 10 Antiplatelet Agents Action: inhibit the aggregation of platelets  Treat clients who have had cerebrovascular accidents or myocardial infarctions

11 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 11 Antiplatelets Examples  Aspirin  Abciximab (ReoPro)  Clopidogrel bisulfate (Plavix)

12 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 12 Thrombolytic Agents Action  Convert plasminogen to enzyme fibrinolysin; fibrinolysin dissolves clots Example  Streptokinase (IV) Caution  Hemorrhage


Download ppt "Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved. 19 - 2 Blood."

Similar presentations


Ads by Google